Initiator Pharma A/S (STO: INIT)
Sweden
· Delayed Price · Currency is SEK
8.20
+0.10 (1.23%)
Aug 30, 2024, 5:29 PM CET
Initiator Pharma Statistics
Total Valuation
Initiator Pharma has a market cap or net worth of SEK 459.61 million. The enterprise value is 437.55 million.
Market Cap | 459.61M |
Enterprise Value | 437.55M |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Initiator Pharma has 56.05 million shares outstanding. The number of shares has increased by 128.17% in one year.
Shares Outstanding | 56.05M |
Shares Change (YoY) | +128.17% |
Shares Change (QoQ) | +61.30% |
Owned by Insiders (%) | 9.38% |
Owned by Institutions (%) | 12.05% |
Float | 36.33M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 7.48 |
PS Ratio | n/a |
PB Ratio | 15.96 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.76 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.40
Current Ratio | 15.40 |
Quick Ratio | 15.40 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.71% and return on invested capital (ROIC) is -48.81%.
Return on Equity (ROE) | -72.71% |
Return on Assets (ROA) | -43.56% |
Return on Capital (ROIC) | -48.81% |
Revenue Per Employee | n/a |
Profits Per Employee | -6.14M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.67% in the last 52 weeks. The beta is 0.76, so Initiator Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | -71.67% |
50-Day Moving Average | 8.78 |
200-Day Moving Average | 8.99 |
Relative Strength Index (RSI) | 47.86 |
Average Volume (20 Days) | 27,858 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -20.95M |
Operating Income | -27.47M |
Pretax Income | -25.78M |
Net Income | -18.42M |
EBITDA | n/a |
EBIT | -27.47M |
Earnings Per Share (EPS) | -0.34 |
Balance Sheet
Cash & Cash Equivalents | 22.06M |
Total Debt | n/a |
Net Cash | 22.06M |
Net Cash Per Share | 0.39 |
Equity (Book Value) | 28.81M |
Book Value Per Share | 0.51 |
Working Capital | 28.78M |
Cash Flow
Operating Cash Flow | -23.66M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Initiator Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -128.17% |
Shareholder Yield | -128.17% |
Earnings Yield | -4.17% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |